TheraFaec: Therapeutic Components within Faecal Material

  • Research type

    Research Study

  • Full title

    The effect of faecal components on the composition of the intestinal microbiome; identifying potential future faecal-based bioactive therapies.

  • IRAS ID

    316183

  • Contact name

    Richard Horniblow

  • Contact email

    r.horniblow@bham.ac.uk

  • Sponsor organisation

    University of Birmingham

  • Clinicaltrials.gov Identifier

    ERN_22-0814 ,

  • Duration of Study in the UK

    3 years, 0 months, 2 days

  • Research summary

    There is increasing evidence that components within faecal material could be useful in treating diseases. We know this as a transplant process named 'Faecal Microbial Transplant' (or FMT) where faecal material is transplanted from a healthy donor to a patient can help treat specific diseases. Such diseases include Inflammatory Bowel Disease, Clostridioides difficile infection and potentially diabetes, amongst others currently being examined. However, we don't know what the components are within the faecal material and how they could be exerting their therapeutic effects. Therefore, the goal of this research is to start to understand this in the lab, by examining what is in faecal material and how these components could be working as a medicine.

  • REC name

    London - Surrey Research Ethics Committee

  • REC reference

    22/PR/0982

  • Date of REC Opinion

    22 Jul 2022

  • REC opinion

    Favourable Opinion